target audience: TECH SUPPLIER Publication date: Sep 2024 - Document type: Market Presentation - Doc Document number: # US50763224
Industry Analysis Perspective: Worldwide Life Sciences, 2024
Content
- 27 slides
Get More
When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.
Related Links
Abstract
This IDC presentation offers foundational insights into the worldwide life sciences industry in 2024 for sales, marketing, and product/channel managers at technology companies. By understanding how the industry functions and its dynamics, managers can identify where their companies' technology can be most beneficial, significantly impacting life sciences operations and its sub-verticals, thereby helping their companies capitalize on those opportunities.
The report includes key industry metrics, including financial performance and R&D expenditures. It explores the underlying factors influencing ICT investment decisions by global life sciences organizations in 2024.
"The life sciences industry is in a state of flux, shifting towards more specialized, technology-driven approaches to disease diagnosis, treatment, and prevention. While traditional pharma and medical devices remain dominant, the rapid growth of biotech and the expanding role of contract organizations reflects the industry's adaptability in meeting rapidly evolving global health needs." — Senior Research Analyst Federico Mayr, IDC Health Insights